Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.

about

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged ≥3 to <12 Years.Darunavir: A Review in Pediatric HIV-1 Infection.

P2860

Q35979557-1E528CE6-3CE1-4AC8-8756-4F2153F27ED3 Q38577433-327C8669-3E00-4A38-BD40-FC773743C607

P2860

Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.

Item

http://www.wikidata.org/entity/Q42199714

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Pharmacokinetics of darunavir ...... avir and with or without food.

@en

Pharmacokinetics of darunavir ...... avir and with or without food.

@nl

type

Item

label

Pharmacokinetics of darunavir ...... avir and with or without food.

@en

Pharmacokinetics of darunavir ...... avir and with or without food.

@nl

prefLabel

Pharmacokinetics of darunavir ...... avir and with or without food.

@en

Pharmacokinetics of darunavir ...... avir and with or without food.

@nl

P1476

Pharmacokinetics of darunavir ...... avir and with or without food.

@en

P2093

Els De Paepe

http://www.w3.org/2001/XMLSchema#string

Ludo Lavreys

http://www.w3.org/2001/XMLSchema#string

Marc Vanstockem

http://www.w3.org/2001/XMLSchema#string

Richard M W Hoetelmans

http://www.w3.org/2001/XMLSchema#string

Tanja Stevens

http://www.w3.org/2001/XMLSchema#string

Tony Vangeneugden

http://www.w3.org/2001/XMLSchema#string

Vanitha Sekar

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?

Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.

Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.

Drug excipients.

The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.

P304

346-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.88

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N Kakuda

P577

2014-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27129006

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.

about

P2860

P2860

Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698